- Home
- LTRN vs ALGS Comparison
LTRN vs ALGS Comparison
Compare LTRN & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- ALGS
- Stock Information
- Founded
- LTRN 2013
- ALGS 2018
- Country
- LTRN United States
- ALGS United States
- Employees
- LTRN N/A
- ALGS N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- LTRN Health Care
- ALGS Health Care
- Exchange
- LTRN Nasdaq
- ALGS Nasdaq
- Market Cap
- LTRN 37.2M
- ALGS 32.4M
- IPO Year
- LTRN 2020
- ALGS 2020
- Fundamental
- Price
- LTRN $4.10
- ALGS $5.52
- Analyst Decision
- LTRN Strong Buy
- ALGS Strong Buy
- Analyst Count
- LTRN 1
- ALGS 1
- Target Price
- LTRN $25.00
- ALGS $70.00
- AVG Volume (30 Days)
- LTRN 37.1K
- ALGS 145.7K
- Earning Date
- LTRN 05-15-2025
- ALGS 05-06-2025
- Dividend Yield
- LTRN N/A
- ALGS N/A
- EPS Growth
- LTRN N/A
- ALGS N/A
- EPS
- LTRN N/A
- ALGS N/A
- Revenue
- LTRN N/A
- ALGS $3,270,000.00
- Revenue This Year
- LTRN N/A
- ALGS $583.52
- Revenue Next Year
- LTRN N/A
- ALGS N/A
- P/E Ratio
- LTRN N/A
- ALGS N/A
- Revenue Growth
- LTRN N/A
- ALGS N/A
- 52 Week Low
- LTRN $2.55
- ALGS $3.76
- 52 Week High
- LTRN $7.21
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- LTRN 61.32
- ALGS 48.14
- Support Level
- LTRN $3.80
- ALGS $4.20
- Resistance Level
- LTRN $4.43
- ALGS $6.45
- Average True Range (ATR)
- LTRN 0.33
- ALGS 0.69
- MACD
- LTRN 0.07
- ALGS 0.35
- Stochastic Oscillator
- LTRN 77.79
- ALGS 73.33
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.